1. Anaesthesia and concomitant MAO inhibitor therapy

   Newsletter Article 05 February 2013 Pages: 2 - 2

2. Hallucinations with cough syrup administration

   Newsletter Article 05 February 2013 Pages: 2 - 3

3. Contact dermatitis with transdermal patch administration

   Newsletter Article 05 February 2013 Pages: 3 - 3

4. Eye disorders with transdermal scopolamine : an ADRAC report

   Newsletter Article 05 February 2013 Pages: 3 - 3

5. Alfacalcidol

   Newsletter Article 05 February 2013 Pages: 4 - 4

6. Alfentanil

   Newsletter Article 05 February 2013 Pages: 4 - 4

7. Aminoglycosides

   Newsletter Article 05 February 2013 Pages: 4 - 4

8. Antihypertensives

   Newsletter Article 05 February 2013 Pages: 4 - 4

9. Benzodiazepines

   Newsletter Article 05 February 2013 Pages: 4 - 4

10. Bretylium overdose

    Newsletter Article 05 February 2013 Pages: 4 - 5

11. Captopril

    Newsletter Article 05 February 2013 Pages: 5 - 5

12. Captopril/enalapril

    Newsletter Article 05 February 2013 Pages: 5 - 5

13. Carbimazole/propylthiouracil

    Newsletter Article 05 February 2013 Pages: 5 - 5

14. Cefalexin/oxacillin/penicillin

    Newsletter Article 05 February 2013 Pages: 5 - 5

15. Chloral hydrate overdose

    Newsletter Article 05 February 2013 Pages: 5 - 5

16. Chlordiazepoxide

    Newsletter Article 05 February 2013 Pages: 5 - 5

17. Contraceptives, oral

    Newsletter Article 05 February 2013 Pages: 5 - 6

18. Corticosteroids

    Newsletter Article 05 February 2013 Pages: 6 - 6

19. Cotrimoxazole

    Newsletter Article 05 February 2013 Pages: 6 - 6

20. Dibrompropamide

    Newsletter Article 05 February 2013 Pages: 6 - 6

21. Diclofenac

    Newsletter Article 05 February 2013 Pages: 6 - 6

22. Digitoxin/digoxin

    Newsletter Article 05 February 2013 Pages: 6 - 6

23. Digoxin see Digitoxin/digoxin

    Newsletter Article 05 February 2013 Pages: 6 - 6

24. Diphencyprone

    Newsletter Article 05 February 2013 Pages: 6 - 6

25. Enalapril see Captopril/enalapril

    Newsletter Article 05 February 2013 Pages: 6 - 6

26. Ethchlorvynol

    Newsletter Article 05 February 2013 Pages: 6 - 6

27. Famotidine/ranitidine

    Newsletter Article 05 February 2013 Pages: 6 - 7

28. Fentanyl

    Newsletter Article 05 February 2013 Pages: 7 - 7

29. Fentanyl/suxamethonium/thiopental sodium

    Newsletter Article 05 February 2013 Pages: 7 - 7

30. Fluconazole

    Newsletter Article 05 February 2013 Pages: 7 - 7

31. Griseofulvin

    Newsletter Article 05 February 2013 Pages: 7 - 8

32. Heparin

    Newsletter Article 05 February 2013 Pages: 8 - 8

33. Interferon alpha

    Newsletter Article 05 February 2013 Pages: 8 - 8

34. Interferon gamma

    Newsletter Article 05 February 2013 Pages: 8 - 8

35. Ketoconazole see Fluconazole

    Newsletter Article 05 February 2013 Pages: 8 - 8

36. Lisinopril see Lovastatin interaction

    Newsletter Article 05 February 2013 Pages: 8 - 8

37. Lovastatin interaction

    Newsletter Article 05 February 2013 Pages: 8 - 8

38. Mexiletine

    Newsletter Article 05 February 2013 Pages: 8 - 8

39. Mitoxantrone

    Newsletter Article 05 February 2013 Pages: 8 - 9

40. Monoamine oxidase inhibitors

    Newsletter Article 05 February 2013 Pages: 9 - 9

41. Morphine

    Newsletter Article 05 February 2013 Pages: 9 - 9

42. Nifedipine

    Newsletter Article 05 February 2013 Pages: 9 - 9

43. Oxacillin see Cefalexin/oxacillin/penicillin

    Newsletter Article 05 February 2013 Pages: 9 - 9

44. Penicillin see Cefalexin/oxacillin/penicillin

    Newsletter Article 05 February 2013 Pages: 9 - 9

45. Penicillins

    Newsletter Article 05 February 2013 Pages: 9 - 9

46. Phenylmercuric nitrate

    Newsletter Article 05 February 2013 Pages: 9 - 10

47. Piromidic acid

    Newsletter Article 05 February 2013 Pages: 10 - 10

48. Piroxicam

    Newsletter Article 05 February 2013 Pages: 10 - 10

49. Prednisolone withdrawal

    Newsletter Article 05 February 2013 Pages: 10 - 10

50. Propranolol withdrawal

    Newsletter Article 05 February 2013 Pages: 10 - 10